Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> VERTEX PHARMACEUTICALS Latest News

JUN 24, 2014 - Reuters

A Must Read - Share

Vertex cystic fibrosis combo succeeds in key late-stage trials

(Reuters) - A combination of Vertex Pharmaceuticals Inc's cystic fibrosis drug Kalydeco and its experimental lumacaftor succeeded in improving lung function in a pair of closely watched late-stage trials of patients with the most common genetic mutation associated with the rare lung disease.

Tags: Vertex cystic fibrosis combo succeeds in key late-stage trials,  Vertex Pharmaceuticals Latest News